This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Dystrophic epidermolysis bullosa

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Dystrophic epidermolysis bullosa

Dystrophic epidermolysis bullosa is characterised by subepidermal blistering below the dermoepidermal junction.

Mutations in the type VII collagen gene which results in disordered anchoring fibrils at the dermal-epidermal junction has been recognized as the cause.

The condition may be

  • 1. autosomal dominant - a milder form of the disease
  • 2. autosomal recessive - causes severe symptoms (1)

Scarring is common; permanent nail loss is common. Extracutaneous manifestations can also be seen in dystrophic epidermolysis bullosa which are more common in patients with the recessive form of the disease.

Most frequent sites of involvement include:

  • teeth - Gingival blisters or erosion, enamel hypoplasia, dental caries,
  • gastrointestinal tract - dysphagia, oesophageal stricture or stenosis, pyloric stenosis, anal stricture, chronic constipation and fecal impaction.
  • upper respiratory tract - chronic hoarseness, inspiratory stridor and laryngeal stenosis or obstruction.
  • genitourinary tract
  • eyes - chronic hoarseness, inspiratory stridor and laryngeal stenosis or obstruction
  • cardiovascular system - dilated cardiomyopathy
  • anaemia and growth retardation (1)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.